While the governments intend to modernize regulation in the medical sector is commendable, there is an undeniable cloud of concern shrouding the draft of the Medical Devices and Cosmetics Bill, 2023. The current draft is riddled with an alarming number of loopholes, raising serious doubts about its efficacy and impact. Our Partner (Head – Pharma & Healthcare) Ashwin Sapra shares his views in an article published in Medical Buyer. (Photo Credits: Medical Buyer)
